MedTrace Logo

Effect of Different Hyaluronic Acids in the Treatment of Subdeltoid Bursitis

NCT07729514 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-07-30

No results posted yet for this study

Summary

The study employs a double-blind, randomized clinical trial design with 50 patients diagnosed with subdeltoid bursitis. Participants are divided into two groups: ultra-high-molecular-weight hyaluronic acid or high-molecular-weight hyaluronic acid injection. All injections are guided by ultrasound. Assessments are conducted before treatment and at 1 week, 1 month, and 3 months post-treatment.

Conditions

  • Subdeltoid Bursitis of the Shoulder

Interventions

DRUG

ultra-high molecular weight hyaluronic acid injection

ultra-high molecular weight hyaluronic acid

DRUG

high molecular weight hyaluronic acid injection

Ultrasound-guided injection into subdeltoid bursa

Sponsors & Collaborators

  • Shin Kong Wu Ho-Su Memorial Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-06-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07729514 on ClinicalTrials.gov